about
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient miceVasodilator therapy with hydralazine induces angiotensin AT receptor-mediated cardiomyocyte growth in mice lacking guanylyl cyclase-A.Is hypertensive vascular disease reversible?Regression of left ventricular hypertrophy during treatment with antihypertensive agents.Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat.Predicting and preventing hypertension and associated cardiovascular disease.Influence of isradipine treatment on left ventricular and coronary vascular hypertrophy in spontaneously hypertensive rats.Regression of cardiovascular structural changes--a preventive strategy.Relationship between hypertension and angina pectoris.Effects of antihypertensive treatment on left ventricular hypertrophy in patients with essential hypertension.Complete reversibility of physiological coronary vascular abnormalities in hypertrophied hearts produced by pressure overload in the ratHypertensive left ventricular hypertrophy: pathophysiology, assessment and treatment.Vascular hypertrophy in borderline hypertension: relationship to blood pressure and sympathetic drive.Control of blood pressure and reduction of echocardiographically assessed left ventricular mass with one-daily timolol.Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats.Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats.Hemodynamic effects of prolonged treatment with diltiazem in conscious normotensive and spontaneously hypertensive rats.Reduced left ventricular hypertrophy following long-term water deprivation in the young spontaneously hypertensive rat.Changes in collagen phenotypes during progression and regression of cardiac hypertrophy.
P2860
Q28362795-C5404668-80E5-46F4-A43E-34A2058D8B5FQ33730624-6949738E-E918-4BD2-8C90-0BA5FD278222Q34449006-005580A0-503F-4A11-89FC-063C0D6F2DB5Q34516447-BB01379F-C8A8-46F7-BB53-4D2E924E1FD0Q36296915-737C6585-C359-44D4-A1B5-D693C3EFE1A9Q36576349-D569E97E-3F97-498F-A53D-BB351F512593Q36745465-03AB0A18-671B-4127-B9D7-19F79636F828Q37859548-40F7D8EF-790D-4146-908D-0E81DB1821EEQ39889627-7CD6734F-1EA3-43FB-A1E9-ECD58E12E38BQ39896526-1064BD6E-7968-491C-A1B2-4A2A5A22ED0FQ40380091-70B181E1-0BAD-4A71-94F2-0E1715CCF5BCQ41087908-35F75788-CEB6-4E45-A8F9-F12FCDF65ADFQ41499651-BB1E8DFF-03D5-40D1-BB20-3CA89E20BBB0Q41970399-3EC5126D-CA99-4C7D-8546-E6AD40EEDA73Q42636392-37C49B2E-4A23-4323-B877-03C0E51FF04CQ44644755-DDDD5C85-ED37-426B-81F4-7DE4F880C9D8Q48541612-A170F173-96BE-491A-8A76-5C4078024D82Q49162371-5491649B-5628-4CCD-9D7A-212B8E9A0AC0Q50908555-FAF8384D-3126-494E-A5B1-29E10776F80D
P2860
description
1977 nî lūn-bûn
@nan
1977 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Cardiac hypertrophy and antihypertensive therapy
@ast
Cardiac hypertrophy and antihypertensive therapy
@en
Cardiac hypertrophy and antihypertensive therapy
@nl
type
label
Cardiac hypertrophy and antihypertensive therapy
@ast
Cardiac hypertrophy and antihypertensive therapy
@en
Cardiac hypertrophy and antihypertensive therapy
@nl
prefLabel
Cardiac hypertrophy and antihypertensive therapy
@ast
Cardiac hypertrophy and antihypertensive therapy
@en
Cardiac hypertrophy and antihypertensive therapy
@nl
P2093
P356
P1476
Cardiac hypertrophy and antihypertensive therapy
@en
P2093
P304
P356
10.1093/CVR/11.5.427
P407
P577
1977-09-01T00:00:00Z